Bloomberg The Food and Drug Administration will hold a meeting of its Vaccines and Related Biological Products Advisory Committee on Oct. 10.
The panel will discuss influenza vaccine strain selection for the 2025 southern hemisphere season and pandemic preparedness for avian influenza, according to a notice published in the Federal Register.
The committee will also hear overviews of FDA research programs.